Latest Lead News

Echo IQ has formally lodged its FDA 510(k) submission for EchoSolv HF, an AI-driven heart failure diagnostic software validated by Mayo Clinic data, aiming to tap into a $60 billion US market.

Rent.com.au has locked in up to $5.5 million in growth capital by underwriting the exercise of its remaining listed options, positioning the company for accelerated profitability and expansion of its RentBond® loan book.

Pinnacle Minerals announces a strategic leadership reshuffle, appointing William Witham as Managing Director and CEO, Stephen Ross as Non-Executive Chairman, and welcoming Jay Stephenson to the board.

Xstate Resources has launched a prospectus offering nearly 97 million free attaching options to placement participants and contractors, alongside a nominal cleansing offer to remove trading restrictions on recent share issuances.

Apiam Animal Health Limited shareholders are set to vote on a scheme of arrangement offering $0.87 cash per share or a mix of cash and unlisted scrip in a new holding company controlled by Adamantem Capital. The Independent Expert deems the cash offer fair and reasonable, while scrip options carry liquidity and minority risks.

Minbos Resources has launched a prospectus offering nearly 118 million free attaching options to recent Placement investors, aiming to bolster funding for its Cabinda fertilizer plant amid operational and geopolitical challenges in Angola.

GenusPlus Group, partnering with ACCIONA, has won a $1.6 billion contract to build Victoria’s Western Renewables Link, a major transmission project set to power up to one million homes with renewable energy.

Goodman Group has announced an estimated ordinary dividend of AUD 0.15 per security for the six months ending December 2025, with payment scheduled for February 2026. The dividend is unfranked, and final details will be confirmed in February.

Amplitude Energy has addressed an ASX query regarding the delayed filing of a director’s interest change, attributing it to an administrative oversight while affirming its compliance framework.

Medallion Metals has completed a Feasibility Study for its Ravensthorpe Gold Project, confirming robust economics and a clear pathway to near-term gold and copper production leveraging existing infrastructure in Western Australia.

An independent meta-analysis presented at the ASH Annual Meeting reveals Mesoblast’s remestemcel-L achieves superior remission rates and safety outcomes compared to ruxolitinib in treating steroid-refractory acute graft-versus-host disease.

ABx Group has secured a new five-year exploration licence in northern Tasmania, expanding its rare earths tenure between key deposits and advancing its high-value rare earth product development.